Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × Octreotide × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 3 NET 1 Gastrointestinal 1 CNS 1

Conditions

Neuroendocrine Tumors 12 Gastro-enteropancreatic neuroendocrine tumor 4 Carcinoid Tumor 3 Neoplasms 2 Carcinoma, Islet Cell 2 Adenoma, Islet Cell 2 Vipoma 1 Somatostatinoma 1 Serotonin Syndrome 1 Pancreatic Neuroendocrine Tumor G2 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Insulinoma 1 Glucagonoma 1 Gastrinoma 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Acromegaly 1

Interventions

pasireotide 1 lanreotide 1 Octreotide 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05364944 2025-11-17

OXTEND-01

Debiopharm International SA

Phase 1 Terminated

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon ⚡